Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
Open | $10.26 |
Close | $10.38 |
Volume / Avg. | 672.74K / 647.27K |
Day Range | 10.11 - 10.55 |
52 Wk Range | 6.02 - 13.14 |
Market Cap | $751.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 5.25% |
Days to Cover | 7.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), 89bio (NASDAQ:ETNB), Celcuity (NASDAQ:CELC) and Replimune Group (NASDAQ:REPL).
There is no analysis for Zymeworks.
Zymeworks has a consensus price target of $19.43.
The stock price for Zymeworks (NASDAQ: ZYME) is $10.63 last updated July 23, 2024 at 4:19 PM EDT.
There are no upcoming dividends for Zymeworks.
Zymeworks’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.